Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q2 2013 · 10-Q
Revenue$3.24B$3.24B+4.2% vs Q2 2012 Net Income$277.40M$277.40M+18.6% vs Q2 2012 EPS Diluted$0.76$0.76+20.6% vs Q2 2012 Gross Profit$1,363,200,000+3.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flowderived$478,400,000−5.7% Free Cash Flowderived$412,800,000−6.6% Margins · derivedGross margin42.1%−0.4 pt vs Q2 2012
Operating margin11.6%−0.2 pt vs Q2 2012
Net margin8.6%+1.0 pt vs Q2 2012
ended Jun 29, 2013 · filed Aug 2, 2013 · 34 d after period end